Chemical Component Summary

Name5-(4-azanyl-1-propan-2-yl-pyrazolo[3,4-d]pyrimidin-3-yl)-1,3-benzoxazol-2-amine
Identifiers5-(4-azanyl-1-propan-2-yl-pyrazolo[3,4-d]pyrimidin-3-yl)-1,3-benzoxazol-2-amine
FormulaC15 H15 N7 O
Molecular Weight309.326
TypeNON-POLYMER
Isomeric SMILESCC(C)n1c2c(c(n1)c3ccc4c(c3)nc(o4)N)c(ncn2)N
InChIInChI=1S/C15H15N7O/c1-7(2)22-14-11(13(16)18-6-19-14)12(21-22)8-3-4-10-9(5-8)20-15(17)23-10/h3-7H,1-2H3,(H2,17,20)(H2,16,18,19)
InChIKeyGYLDXIAOMVERTK-UHFFFAOYSA-N

Chemical Details

Formal Charge0
Atom Count38
Chiral Atom Count0
Bond Count41
Aromatic Bond Count20

Drug Info: DrugBank

DrugBank IDDB11836 
NameSapanisertib
Groups investigational
DescriptionSapanisertib has been used in trials studying the treatment of HCC, Solid Tumor, Gliosarcoma, Liver Cancer, and Glioblastoma, among others.
Synonyms
  • Sapanisertib
  • Sapanisertib Hydrochloride
  • Sapanisertib Diphosphate
Categories
  • Heterocyclic Compounds, Fused-Ring
  • Purines
CAS number1224844-38-5

Related Resource References

Resource NameReference
Pharos CHEMBL3545097
PubChem 45375953
ChEMBL CHEMBL3545097
ChEBI CHEBI:91450